Published in Medicine and Law Weekly, May 19th, 2006
Fifteen million dollars may be a bargain once savings are considered.
"Companies using patent litigation to delay generic entrants from coming to the market can potentially save their brand anywhere from $60,000 to $8 million per day, depending on the financial success of the drug," said Elio Evangelista, senior research analyst at Cutting Edge Information and lead author of "Defending Brand Revenue: Pharmaceutical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly